Skip to content
NASDAQ · CHEMICALS & ALLIED PRODUCTS · LARGE CAP

Balchem Corp. BCPC

17 fiscal years on record · USD · FY2025 reported · SEC filings only
3 YEARS OF DIVIDEND GROWTH
$1.0B
▲ 8.8% YoY
$154.8M
▲ 20.5% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. As of December 31, 2025, it employed approximately 1,352 full-time employees worldwide, of whom approximately 16% were covered by collective-bargaining agreements. It holds over 130 patents and over 400 registered trademarks in the United States and overseas. Its three reportable segments are Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition and Health segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition and Health segment provides nutritional products derived from microencapsulation and chelation technologies, in addition to the essential nutrient choline chloride. The Specialty Products segment re-packages and distributes performance gases and chemicals, notably ethylene oxide, propylene oxide and ammonia, for various customer uses. Balchem Corporation was incorporated in the State of Maryland in 1967.

Written from the business description in Balchem Corporation's annual report to the U.S. Securities and Exchange Commission, filed 20 February 2026. Every sentence was checked against that document before publication.

Growth

USD 1.0B
Revenue, FY2025 · full 17-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.0 · Net income 0.2
0.5B1.0B
2009201220152018202120242025
Compound annual growth
+3.2%
+8.1%
+6.5%
+9.8%
+13.7%
+12.8%
+10.0%
+10.8%
+13.5%
+12.8%
+9.7%
+10.1%
+10.6%
+33.7%
+49.9%
+29.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +8.1% a year over the five years to FY2025 — but profit grew faster: net income at +12.8%, earnings per share at +12.8%.

The share count fell from 0.03B to 0.03B — the buyback concentrates the same profit into fewer slices.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

15 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 20.2% · Net 14.9%
10%20%
200920172025
ROE
FY2025 · ROE 12.9%
10%20%
200920172025
Three returns, three denominators.

Each USD of equity produced 13 cents of profit this year.

Cash & shareholders

USD 126.6M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2022 · FCF 89.5
50M100M
200920172025
Net buybacks $M Dividends $M
FY2025 · Dividends 28.3 · Net buybacks 98.3
50M100MDividendsNet buybacks
200920112013201520172019202120232025

USD 28.3M in dividends and USD 98.3M in buybacks — 82% of the year's profit went back to shareholders.

Total assetsUSD 1.7B
EquityUSD 1.3B
CashUSD 74.6M
Current ratio2.07×

Equity funds 75% of total assets.

The 17-year record

17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
BCPC, 17-year financial record
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B1.01.00.90.90.80.70.60.60.60.60.60.50.30.30.30.30.2
Operating income $B0.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.00.0
EBITDA $B0.30.20.20.20.20.20.10.20.10.10.10.10.10.10.10.10.0
Income tax $B0.00.00.00.00.00.00.00.0−0.00.00.00.00.00.00.00.00.0
Net income $B0.20.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.0
Free cash flow $B◌◌◌0.10.10.10.10.10.10.10.10.10.00.00.00.00.0
EPS, diluted $4.753.933.353.252.942.602.452.422.791.751.891.691.451.321.281.120.93
Dividend / sh $0.960.870.790.71◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout %1820212019201917131915150291197
ROE %12.911.710.911.611.310.811.112.015.811.414.014.614.815.818.519.920.5
Shares out B0.030.030.030.030.030.030.030.030.030.030.030.030.030.030.030.03◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 84 reconciliationsAUDITED

Reconciled in 17 of the 17 fiscal years we could check. Four checks were skipped: the balance sheet is not tagged before 2009. Two checks were skipped: EPS is not tagged before 2009. Two checks were skipped: revenue is not tagged before 2009.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityChemicals & Allied Products
Listed onNASDAQ
Incorporated inMaryland
Fiscal year endsDecember 31
Data on record since2008

Share this section

Download image